NCT01695226View on ClinicalTrials.gov

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2004

Primary Completion Date

July 31, 2007

Conditions
Breast NeoplasmsBreast Cancer
Interventions
DRUG

celecoxib

pre-operative celecoxib (400 mg) twice daily for two to three weeks

DRUG

Placebo

pre-operative placebo twice daily for two to three weeks

Trial Locations (1)

6229 HX

University Hospital Maastricht, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT01695226 - Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer | Biotech Hunter | Biotech Hunter